# A Study of the Abuse Liability Potential of Cenobamate in Recreational Drug Users

> **NCT03509285** · PHASE1 · COMPLETED · sponsor: **SK Life Science, Inc.** · enrollment: 53 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Alprazolam Placebo
- **DRUG:** Cenobamate placebo
- **DRUG:** Alprazolam
- **DRUG:** Cenobamate

## Key facts

- **NCT ID:** NCT03509285
- **Lead sponsor:** SK Life Science, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-08
- **Primary completion:** 2017-11-18
- **Final completion:** 2017-12-15
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2024-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03509285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03509285, "A Study of the Abuse Liability Potential of Cenobamate in Recreational Drug Users". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT03509285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*